Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Minden

Showing results (81-90 of 308) with videos related to

Pageof 31
Sort By:
Cell Death & Disease|August 5, 2023
Heterogeneity in leukemia cells that escape drug-induced senescence-like stateDavid Miller, Kyra Kerkhofs, Farnoosh Abbas-Aghababazadeh, et al.
Leukemia Research|January 30, 2013
High-dose cytarabine-based consolidation shows superior results for older AML patients with intermediate risk cytogenetics in first complete remissionMona Hassanein, Eshetu G Atenafu, Andre C Schuh, et al.
Psycho-Oncology|November 15, 2011
Traumatic stress in acute leukemiaGary Rodin, Dora Yuen, Ashley Mischitelle, et al.
Leukemia Research|September 4, 2012
Outcomes of adult patients with relapsed acute lymphoblastic leukemia following frontline treatment with a pediatric regimenElena Liew, Eshetu G Atenafu, Aaron D Schimmer, et al.
Haematologica|July 18, 2015
Increased pressure alters plasma membrane dynamics and renders acute myeloid leukemia cells resistant to daunorubicinVictor Sanjit Nirmalanandhan, Rose Hurren, William D Cameron, et al.
Leukemia Research|October 15, 2022
A 5-microRNA signature derived from core binding factor-AML is predictive in adult and childhood AMLMartino Marco Gabra, Jonathan Tak-Sum Chow, Taehyung Kim, et al.
British Journal of Haematology|September 17, 2013
Treatment of elderly patients with acute lymphoblastic leukaemia using a paediatric-based protocolMarc Poch Martell, Eshetu G Atenafu, Mark D Minden, et al.
Cancers|May 13, 2026
Extramedullary AML: Clinical and Molecular FeaturesYael Morgenstern, Claire Andrews, Eshetu G Atenafu, et al.
Ejhaem|July 18, 2022
Quality of life and socioeconomic indicators associated with survival of myeloid leukemias in CanadaSonya Cressman, Donna E Hogge, Mark D Minden, et al.
Plos One|November 5, 2010
Functional characterization of FLT3 receptor signaling deregulation in acute myeloid leukemia by single cell network profiling (SCNP)David B Rosen, Mark D Minden, Steven M Kornblau, et al.
Pageof 31

Showing results (81-90 of 308) with videos related to

Sort By:
Pageof 31
Cell Death & Disease|August 5, 2023
Heterogeneity in leukemia cells that escape drug-induced senescence-like stateDavid Miller, Kyra Kerkhofs, Farnoosh Abbas-Aghababazadeh, et al.
Leukemia Research|January 30, 2013
High-dose cytarabine-based consolidation shows superior results for older AML patients with intermediate risk cytogenetics in first complete remissionMona Hassanein, Eshetu G Atenafu, Andre C Schuh, et al.
Psycho-Oncology|November 15, 2011
Traumatic stress in acute leukemiaGary Rodin, Dora Yuen, Ashley Mischitelle, et al.
Leukemia Research|September 4, 2012
Outcomes of adult patients with relapsed acute lymphoblastic leukemia following frontline treatment with a pediatric regimenElena Liew, Eshetu G Atenafu, Aaron D Schimmer, et al.
Haematologica|July 18, 2015
Increased pressure alters plasma membrane dynamics and renders acute myeloid leukemia cells resistant to daunorubicinVictor Sanjit Nirmalanandhan, Rose Hurren, William D Cameron, et al.
Leukemia Research|October 15, 2022
A 5-microRNA signature derived from core binding factor-AML is predictive in adult and childhood AMLMartino Marco Gabra, Jonathan Tak-Sum Chow, Taehyung Kim, et al.
British Journal of Haematology|September 17, 2013
Treatment of elderly patients with acute lymphoblastic leukaemia using a paediatric-based protocolMarc Poch Martell, Eshetu G Atenafu, Mark D Minden, et al.
Cancers|May 13, 2026
Extramedullary AML: Clinical and Molecular FeaturesYael Morgenstern, Claire Andrews, Eshetu G Atenafu, et al.
Ejhaem|July 18, 2022
Quality of life and socioeconomic indicators associated with survival of myeloid leukemias in CanadaSonya Cressman, Donna E Hogge, Mark D Minden, et al.
Plos One|November 5, 2010
Functional characterization of FLT3 receptor signaling deregulation in acute myeloid leukemia by single cell network profiling (SCNP)David B Rosen, Mark D Minden, Steven M Kornblau, et al.
Pageof 31